Showing results (291-300 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|July 7, 2017
Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibitionTakuya Osada, Michael A Morse, Amy Hobeika, et al.
Oncoimmunology|July 7, 2017
Arginase inhibition suppresses lung metastasis in the 4T1 breast cancer model independently of the immunomodulatory and anti-metastatic effects of VEGFR-2 blockadeChiara Secondini, Oriana Coquoz, Lorenzo Spagnuolo, et al.
Oncoimmunology|July 7, 2017
MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastomaElisa Brandetti, Irene Veneziani, Ombretta Melaiu, et al.
Oncoimmunology|July 7, 2017
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophilsValeria Lucarini, Giovanna Ziccheddu, Iole Macchia, et al.
Oncoimmunology|July 7, 2017
Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironmentAliyah M Weinstein, Lu Chen, Emily A Brzana, et al.
Oncoimmunology|July 7, 2017
The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survivalVanessa Stache, Lydia Verlaat, Marcel Gätjen, et al.
Oncoimmunology|June 7, 2018
Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)Shlomo Elias, Shira Kahlon, Rebecca Kotzur, et al.
Oncoimmunology|June 7, 2018
Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapyFrederick S Varn, Laura J Tafe, Christopher I Amos, et al.
Oncoimmunology|June 7, 2018
TFAM is a novel mediator of immunogenic cancer cell deathMinghua Yang, Changfeng Li, Shan Zhu, et al.
Oncoimmunology|June 7, 2018
C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancerSongyang Wu, Hongyong He, Hao Liu, et al.
Pageof 379